Suppression of cerebral aneurysm formation in rats by a tumor necrosis factor–α inhibitor
Authors:
- 1 May 2014
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 120 (5) , 1193-1200
Abstract
Object: Although cerebral aneurysmal subarachnoid hemorrhage is a devastating disease for humans, effective medical treatments have not yet been established. Recent reports have shown that regression of some inflammatory-related mediators has protective effects in experimental cerebral aneurysm models. This study corroborated the effectiveness of tumor necrosis factor–α (TNF-α) inhibitor for experimentally induced cerebral aneurysms in rats. Methods: Five-week-old male rats were prepared for induction of cerebral aneurysms and divided into 3 groups, 2 groups administered different concentrations of a TNF-α inhibitor (etanercept), and 1 control group. One month after aneurysm induction, 7-T MRI was performed. The TNF-α inhibitor groups received subcutaneous injection of 25 μg or 2.5 μg of etanercept, and the control group received subcutaneous injection of normal saline every week. The TNF-α inhibitor administrations were started at 1 month after aneurysm induction to evaluate its suppressive effects on preexisting cerebral aneurysms. Arterial circles of Willis were obtained and evaluated 3 months after aneurysm induction. Results: Rats administered a TNF-α inhibitor experienced significant increases in media thickness and reductions in aneurysmal size compared with the control group. Immunohistochemical staining showed that treatment with a TNF-α inhibitor suppressed matrix metalloproteinase (MMP)–9 and inducible nitric oxide synthase (iNOS) expression through the luminal surface of the endothelial cell layer, the media and the adventitia at the site of aneurysmal formation, and the anterior cerebral artery–olfactory artery bifurcation. Quantitative polymerase chain reaction also showed suppression of MMP-9 and iNOS by TNF-α inhibitor administration. Conclusions: Therapeutic administration of a TNF-α inhibitor significantly reduced the formation of aneurysms in rats. These data also suggest that TNF-α suppression reduced some inflammatory-related mediators that are in the downstream pathway of nuclear factor-κB.Keywords
This publication has 35 references indexed in Scilit:
- Etanercept, a Widely Used Inhibitor of Tumor Necrosis Factor-α (TNF- α), Prevents Retinal Ganglion Cell Loss in a Rat Model of GlaucomaPLOS ONE, 2012
- Aspirin as a Promising Agent for Decreasing Incidence of Cerebral Aneurysm RuptureStroke, 2011
- The Development and the Use of Experimental Animal Models to Study the Underlying Mechanisms of CA FormationBioMed Research International, 2010
- Simvastatin Suppresses the Progression of Experimentally Induced Cerebral Aneurysms in RatsStroke, 2008
- Macrophage-Derived Matrix Metalloproteinase-2 and -9 Promote the Progression of Cerebral Aneurysms in RatsStroke, 2007
- Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodelingNeurological Research, 2006
- Impaired Progression of Cerebral Aneurysms in Interleukin-1β–Deficient MiceStroke, 2006
- TNF‐α in vivo stimulates apoptosis in fibroblasts through caspase‐8 activation and modulates the expression of pro‐apoptotic genesJournal of Cellular Physiology, 2004
- Disruption of Gene for Inducible Nitric Oxide Synthase Reduces Progression of Cerebral AneurysmsStroke, 2003
- Inflammation and Matrix Metalloproteinases in the Enlarging Abdominal Aortic AneurysmArteriosclerosis, Thrombosis, and Vascular Biology, 1995